CClinicalTrials.gg
Not yet recruitingNCT06593171Updated Sep 19, 2024

Decreasing the Stigma of Mental Illness Among Health Science Students Through a Mentoring Program

An interventional study of Mentoring program and Control (placebo) group in Social Stigma, sponsored by Universidad del Desarrollo. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by Universidad del Desarrollo · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
102
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Stigma towards people with mental health problems is a serious public health problem that limits access to treatment and social participation, in addition to being considered the main barrier to inclusion and quality of health care. This stigma also affects students and health professionals, impacting the quality of care and help seeking in mental health. In this context, it is necessary to develop innovative and effective interventions among university students to reduce this stigma and promote an inclusive and recovery-based approach.

The aim of the present research project is to analyze the effect of a mentoring program on levels of stigma and mental health help-seeking intention in psychology and nursing students. This three-session mentoring program is based on experiential learning and has been validated and adapted to our country. The mentors, professionals with lived experience in mental health, will provide knowledge and experiences to the students through direct contact sessions in the classroom, focusing especially on the processes of recovery and self-determination.

Research question: What is the effect of a mentoring program on levels of stigma and mental health help-seeking intention in health care students?

Within the dependent variables of the study are the measurement of levels of stigma and mental health help-seeking intention in students. The independent variables will be the type of group (experimental and control), age, gender and career.

Methodology: Quantitative study, including the participation of health students in the experimental and control groups. The sample size was determined using the G*Power software. After approval by the institutional ethics committee and signature of the informed consent of the participants, the mentoring program will be implemented in the classroom. For this purpose, the levels of stigma and intention to seek mental health help in both groups will be measured using nationally and internationally validated instruments, before, after and at 4 weeks. Data analysis will be performed using a mixed ANOVA model to compare pre- and post-intervention outcomes between the two groups.

The present study will provide valuable evidence on the effectiveness of mentoring-based interventions in reducing stigma in health care students, a key group in the future provision of care for people with mental health problems. The results will also lay the groundwork for larger-scale studies to assess the impact of the intervention in other groups and settings, with the potential to significantly improve the quality of care and well-being of patients and their families.

02

Conditions studied

  • Social Stigma

Browse trials for

03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • University students from health careers
  • Sign the informed consent form.

Exclusion criteria

Exclusion Criteria:

  • Be under 18 years of age.
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
102 participants (estimated)

Study arms

  • Active comparator
    Control group

    No intervention group

    Behavioral: Control (placebo) group

  • Experimental
    Experimental group

    Intervention group. In detail, the intervention has a total of 3 participatory sessions via videoconference, with an average duration of 90 minutes per session, with a maximum number of 3 to 4 students per mentor. Each session is accompanied by a reflective log of the activities and observations made by the students of an evaluated nature, as well as reading prior to session n°1 and n°2. In addition, the anonymous evaluation of the level of stigma before and after the implementation, both in the group of students and mentors, is included, as well as a follow-up of the measurements regarding these evaluations. At the professional level, a 6-hour pedagogical intervention focused on stigma reduction for the training of health students towards people with psychiatric illnesses will be provided to all health professionals involved, with a certificate of participation delivered at the end of the sessions. The sessions must have minimum material implements such as an equipped classroom, proj

    Behavioral: Mentoring program

Interventions

  • BehavioralMentoring program

    This three-session mentoring program is based on experiential learning and has been validated and adapted to our country. The mentors, professionals with lived experience in mental health, will provide knowledge and experiences to the students through direct contact sessions in the classroom, focusing especially on the processes of recovery and self-determination.

  • BehavioralControl (placebo) group

    This group will not receive any intervention. However, they will be invited to participate in stigma education after the study is completed.

05

What researchers measure

Primary outcomes

  1. Attribution Questionnaire (AQ-27)

    This 27-item, 9-factor instrument has been widely used to measure levels of stigma towards people with mental health problems in the general population and university students nationally and globally. It presents a vignette of a case of a person diagnosed with schizophrenia, where various stereotypes, prejudices and behaviors around him are assessed and measured (anger, pity, dangerousness, fear, avoidance, guilt, segregation and coercion). The instrument uses a 9-point Likert-type response scale, where higher scores represent higher levels of stigma. Specifically, its Spanish version has demonstrated adequate psychometric properties for use in a university population (Saavedra et al., 2021).

    Time frame: At the time of recruitment, immediately after the end of the study and the 4-week follow-up.

  2. Mental Help Seeking Intention Scale (MHSIS)

    A 3-item instrument designed to measure respondents\' intention to seek help from a mental health professional if one were to have a mental health problem (Hamer \& Spiker, 2018). The response scale is a 7-point Likert-type, where a higher score indicates a greater intention to seek help. This instrument has been shown to possess psychometric properties suitable for use with college students, in addition to possessing evidence of predictive validity (Hamer \& Spiker, 2018).

    Time frame: At the time of recruitment, immediately after the end of the study and the 4-week follow-up.

06

Study locations

No study locations are listed for this record.

07

Registry details

Key details

Study ID
NCT06593171
Lead sponsor
Universidad del Desarrollo
Responsible party
Matías E. Rodríguez-Rivas (Principal Investigator, Universidad del Desarrollo) — Principal investigator
First posted
Sep 19, 2024
Start date
Aug 2025 (estimated)
Primary completion
Dec 2025 (estimated)
Completion
Mar 2026 (estimated)
Last update
Sep 19, 2024

Study contacts

Matías E. Rodríguez-Rivas, PhD, MSc, RN.
Contact
matrodriguezr@udd.cl
(+56 2) 2327 9110

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion